Getting your player ready...
WASHINGTON — An experimental malaria vaccine has for the first time been shown to safely protect large numbers of children against the mosquito-borne scourge, researchers reported Tuesday in the New England Journal of Medicine. The study involving more than 15,000 newborns and babies in seven African countries found the vaccine cut the risk of being infected with the malaria parasite by about half and the chances of getting fatally ill from an infection by more than a third. While far below the protection provided by many widely used vaccines for other diseases, the results were hailed as a major advance toward an elusive goal in medicine. The Washington Post
